The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.
Humans
Retrospective Studies
Percutaneous Coronary Intervention
/ adverse effects
Treatment Outcome
Myocardial Infarction
/ diagnosis
ST Elevation Myocardial Infarction
/ therapy
Non-ST Elevated Myocardial Infarction
/ diagnostic imaging
Heart Failure
/ therapy
Aortic Valve Stenosis
/ complications
Hospital Mortality
moderate arotic stenosis
myocardia infarction
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
31
03
2023
received:
24
01
2023
accepted:
22
04
2023
medline:
4
7
2023
pubmed:
5
5
2023
entrez:
5
5
2023
Statut:
ppublish
Résumé
Aortic stenosis (AS) is associated with myocardial ischemia through different mechanisms and may impair coronary arterial flow. However, data on the impact of moderate AS in patients with acute myocardial infarction (MI) is limited. This study aimed to investigate the impact of moderate AS in patients presenting with acute myocardial infarction (MI). We conducted a retrospective analysis of all patients who presented with acute MI to all Mayo Clinic hospitals, using the Enterprise Mayo PCI Database from 2005 to 2016. Patients were stratified into two groups: moderate AS and mild/no AS. The primary outcome was all cause mortality. The moderate AS group included 183 (13.3%) patients, and the mild/no AS group included 1190 (86.7%) patients. During hospitalization, there was no difference between both groups in mortality. Patients with moderate AS had higher in-hospital congestive heart failure (CHF) (8.2% vs. 4.4%, p = 0.025) compared with mild/no AS patients. At 1-year follow-up, patients with moderate AS had higher mortality (23.9% vs. 8.1%, p < 0.001) and higher CHF hospitalization (8.3% vs. 3.7%, p = 0.028). In multivariate analysis, moderate AS was associated with higher mortality at 1-year (odds ratio 2.4, 95% confidence interval [1.4-4.1], p = 0.002). In subgroup analyses, moderate AS increased all-cause mortality in STEMI and NSTEMI patients. The presence of moderate AS in acute MI patients was associated with worse clinical outcomes during hospitalization and at 1-year follow-up. These unfavorable outcomes highlight the need for a close follow-up of these patients and for timely therapeutic strategies to best manage these coexisting conditions.
Sections du résumé
BACKGROUND
Aortic stenosis (AS) is associated with myocardial ischemia through different mechanisms and may impair coronary arterial flow. However, data on the impact of moderate AS in patients with acute myocardial infarction (MI) is limited.
AIMS
This study aimed to investigate the impact of moderate AS in patients presenting with acute myocardial infarction (MI).
METHODS
We conducted a retrospective analysis of all patients who presented with acute MI to all Mayo Clinic hospitals, using the Enterprise Mayo PCI Database from 2005 to 2016. Patients were stratified into two groups: moderate AS and mild/no AS. The primary outcome was all cause mortality.
RESULTS
The moderate AS group included 183 (13.3%) patients, and the mild/no AS group included 1190 (86.7%) patients. During hospitalization, there was no difference between both groups in mortality. Patients with moderate AS had higher in-hospital congestive heart failure (CHF) (8.2% vs. 4.4%, p = 0.025) compared with mild/no AS patients. At 1-year follow-up, patients with moderate AS had higher mortality (23.9% vs. 8.1%, p < 0.001) and higher CHF hospitalization (8.3% vs. 3.7%, p = 0.028). In multivariate analysis, moderate AS was associated with higher mortality at 1-year (odds ratio 2.4, 95% confidence interval [1.4-4.1], p = 0.002). In subgroup analyses, moderate AS increased all-cause mortality in STEMI and NSTEMI patients.
CONCLUSION
The presence of moderate AS in acute MI patients was associated with worse clinical outcomes during hospitalization and at 1-year follow-up. These unfavorable outcomes highlight the need for a close follow-up of these patients and for timely therapeutic strategies to best manage these coexisting conditions.
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-165Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2023 Wiley Periodicals LLC.
Références
Iung B, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24(13):1231-1243.
Osnabrugge RLJ, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly. JACC. 2013;62(11):1002-1012.
Danielsen R, Aspelund T, Harris TB, Gudnason V. The prevalence of aortic stenosis in the elderly in Iceland and predictions for the coming decades: the AGES-Reykjavík study. Int J Cardiol. 2014;176(3):916-922.
Rajamannan NM, Evans FJ, Aikawa E, et al. Calcific aortic valve disease: not simply a degenerative process: a review and agenda for research from The National Heart and Lung and Blood Institute Aortic Stenosis Working Group Executive summary: calcific aortic valve disease - 2011 update. Circulation. 2011;124(16):1783-1791.
Garcia D, Camici PG, Durand LG, et al. Impairment of coronary flow reserve in aortic stenosis. J Appl Physiol. 2009;106(1):113-121.
Ahmad Y, Götberg M, Cook C, et al. Coronary hemodynamics in patients with severe aortic stenosis and coronary artery disease undergoing transcatheter aortic valve replacement: implications for clinical indices of coronary stenosis severity. JACC. Cardiovasc Interv. 2018;11(20):2019-2031.
Marquis-Gravel G, Redfors B, Leon MB, Généreux P. Medical treatment of aortic stenosis. Circulation. 2016;134(22):1766-1784.
Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. JACC. 2012;60(16):1581-1598.
Broyd CJ, Sen S, Mikhail GW, Francis DP, Mayet J, Davies JE. Myocardial ischemia in aortic stenosis: insights from arterial pulse-wave dynamics after percutaneous aortic valve replacement. Trends Cardiovascul Med. 2013;23(6):185-191.
Hasdai D, Lev EI, Behar S, et al. Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart Survey of acute coronary syndromes. Eur Heart J. 2003;24(7):623-629.
Singh GK, van der Bijl P, Goedemans L, et al. Prevalence of aortic valve stenosis in patients with st-segment elevation myocardial infarction and effect on long-term outcome. Am J Cardiol. 2021;153:30-35.
Paquin A, Marsit O, Deschênes V, et al. Progression of aortic stenosis after an acute myocardial infarction. Open Heart. 2022;9(1):e002046.
Eberli FR, Ritter M, Schwitter J, et al. Coronary reserve in patients with aortic valve disease before and after successful aortic valve replacement. Eur Heart J. 1991;12(2):127-138.
Rajappan K, Rimoldi OE, Camici PG, Bellenger NG, Pennell DJ, Sheridan DJ. Functional changes in coronary microcirculation after valve replacement in patients with aortic stenosis. Circulation. 2003;107(25):3170-3175.
Gould KL, Carabello BA. Why angina in aortic stenosis with normal coronary arteriograms. Circulation. 2003;107:3121-3123.
Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation. 1993;88(3):993-1003.
Spaan JAE. Mechanical determinants of myocardial perfusion. Basic Res Cardiol. 1995;90(2):89-102.
Hongo M, Goto T, Watanabe N, et al. Relation of phasic coronary flow velocity profile to clinical and hemodynamic characteristics of patients with aortic valve disease. Circulation. 1993;88(3):953-960.
Wiegerinck EM, van de Hoef TP, Rolandi MC, et al. Impact of aortic valve stenosis on coronary hemodynamics and the instantaneous effect of transcatheter aortic valve implantation. Circ: Cardiovasc Interv. 2015;8(8):e002443.
Strange G, Stewart S, Celermajer D, et al. Poor long-term survival in patients with moderate aortic stenosis. JACC. 2019;74(15):1851-1863.
Moon I, Kim M, Choi JW, et al. Early surgery versus watchful waiting in patients with moderate aortic stenosis and left ventricular systolic dysfunction. Korean Circ J. 2020;50(9):791-800.
Spitzer E, Van Mieghem NM, Pibarot P, et al. Rationale and design of the transcatheter aortic valve replacement to UNload the left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. Am Heart J. 2016;182:80-88.